Literature DB >> 27681349

Peripheral nerve involvement in classic homocystinuria: an unusual association.

Miguel Oliveira Santos1, Ruth Geraldes2, Isabel Conceição1.   

Abstract

Classic homocystinuria is one of the most common causes of hereditary hyperhomocysteinemia. It is an autosomal recessive and multisystemic disorder due to cystathionine β-synthase deficiency. We described a case of an 18-year-old Portuguese man with an ischaemic stroke, who was subsequently diagnosed with classic homocystinuria [Thr191Met (c.572C>T) CBS mutation] associated with a sensorimotor neuropathy. The patient had a good clinical and metabolic response to pyridoxine plus methionine-restricted diet after 12 months of treatment. Neurophysiological re-evaluation with nerve conduction studies disclosed an improvement on the peripheral nerve lesion. Central nervous system manifestations in classic homocystinuria have been well documented, but this is to the best of our knowledge the first report of an association with peripheral neuropathy, which improved after hyperhomocysteinemia treatment. 2016 BMJ Publishing Group Ltd.

Entities:  

Year:  2016        PMID: 27681349      PMCID: PMC5051395          DOI: 10.1136/bcr-2016-216255

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  12 in total

1.  European Federation of Neurological Societies/Peripheral Nerve Society guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy: report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society - first revision.

Authors:  P Y K Van den Bergh; R D M Hadden; P Bouche; D R Cornblath; A Hahn; I Illa; C L Koski; J-M Léger; E Nobile-Orazio; J Pollard; C Sommer; P A van Doorn; I N van Schaik
Journal:  Eur J Neurol       Date:  2010-03       Impact factor: 6.089

Review 2.  Inherited metabolic disorders and cerebral infarction.

Authors:  Kavita Kalidas; Réza Behrouz
Journal:  Expert Rev Neurother       Date:  2008-11       Impact factor: 4.618

Review 3.  Inherited metabolic disorders and stroke part 2: homocystinuria, organic acidurias, and urea cycle disorders.

Authors:  Fernando D Testai; Philip B Gorelick
Journal:  Arch Neurol       Date:  2010-02

4.  Central and peripheral nervous system pathology of homocystinuria due to 5,10-methylenetetrahydrofolate reductase deficiency.

Authors:  M Nishimura; K Yoshino; Y Tomita; S Takashima; J Tanaka; K Narisawa; I Kurobane
Journal:  Pediatr Neurol       Date:  1985 Nov-Dec       Impact factor: 3.372

5.  5,10-Methylenetetrahydrofolate reductase deficiency with progressive polyneuropathy in an infant.

Authors:  Megumi Tsuji; Atsushi Takagi; Kiyoko Sameshima; Mizue Iai; Sumimasa Yamashita; Hiroko Shinbo; Noritaka Furuya; Kenji Kurosawa; Hitoshi Osaka
Journal:  Brain Dev       Date:  2010-09-20       Impact factor: 1.961

Review 6.  Folate and homocysteine metabolism in neural plasticity and neurodegenerative disorders.

Authors:  Mark P Mattson; Thomas B Shea
Journal:  Trends Neurosci       Date:  2003-03       Impact factor: 13.837

7.  Insidious peripheral neuropathy occurring under treatment in infantile MTHFR deficiency.

Authors:  A Chaabene-Masmoudi; F Mesrati; J Zittoun; P Landrieu
Journal:  J Inherit Metab Dis       Date:  2009-08-21       Impact factor: 4.982

8.  Enzymatic diagnosis of homocystinuria by determination of cystathionine-ß-synthase activity in plasma using LC-MS/MS.

Authors:  P Alcaide; J Krijt; P Ruiz-Sala; P Ješina; M Ugarte; V Kožich; B Merinero
Journal:  Clin Chim Acta       Date:  2014-09-16       Impact factor: 3.786

Review 9.  Treatment of inherited homocystinurias.

Authors:  Manuel Schiff; Henk J Blom
Journal:  Neuropediatrics       Date:  2012-11-02       Impact factor: 1.947

10.  Production of synthetic methionine-free and synthetic methionine-limited alpha casein: protein foodstuff for patients with homocystinuria due to cystathionine beta-synthase deficiency.

Authors:  Sayed K Goda; Yasmin W Abu Aqel; Mai R Al-Aswad; Fatma A B Rashedy; Amr S Mohamed
Journal:  Protein J       Date:  2010-01       Impact factor: 2.371

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.